These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17017617)

  • 21. Gene therapy with anabolic growth factors to prevent muscle atrophy.
    Schakman O; Thissen JP
    Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):207-13. PubMed ID: 16607118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone supplementation for aging-associated sarcopenia.
    Bhasin S
    J Gerontol A Biol Sci Med Sci; 2003 Nov; 58(11):1002-8. PubMed ID: 14630881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection.
    Lang CH; Frost RA
    Curr Opin Clin Nutr Metab Care; 2002 May; 5(3):271-9. PubMed ID: 11953652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Global therapeutic approach to sarcopenia].
    Burgos Peláez R
    Nutr Hosp; 2006 May; 21 Suppl 3():51-60. PubMed ID: 16768031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-beta1.
    Schmidmaier G; Wildemann B; Heeger J; Gäbelein T; Flyvbjerg A; Bail HJ; Raschke M
    Bone; 2002 Jul; 31(1):165-72. PubMed ID: 12110430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial.
    Grunseich C; Miller R; Swan T; Glass DJ; El Mouelhi M; Fornaro M; Petricoul O; Vostiar I; Roubenoff R; Meriggioli MN; Kokkinis A; Guber RD; Budron MS; Vissing J; Soraru G; Mozaffar T; Ludolph A; Kissel JT; Fischbeck KH;
    Lancet Neurol; 2018 Dec; 17(12):1043-1052. PubMed ID: 30337273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-1 and myostatin mRNA expression in muscle: comparison between 62-77 and 21-31 yr old men.
    Welle S; Bhatt K; Shah B; Thornton C
    Exp Gerontol; 2002 Jun; 37(6):833-9. PubMed ID: 12175483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia.
    Solerte SB; Gazzaruso C; Bonacasa R; Rondanelli M; Zamboni M; Basso C; Locatelli E; Schifino N; Giustina A; Fioravanti M
    Am J Cardiol; 2008 Jun; 101(11A):69E-77E. PubMed ID: 18514630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation.
    Léger B; Derave W; De Bock K; Hespel P; Russell AP
    Rejuvenation Res; 2008 Feb; 11(1):163-175B. PubMed ID: 18240972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myostatin inhibition: a potential performance enhancement strategy?
    Fedoruk MN; Rupert JL
    Scand J Med Sci Sports; 2008 Apr; 18(2):123-31. PubMed ID: 18248537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth factors, muscle function and doping.
    Goldspink G; Wessner B; Bachl N
    Curr Opin Pharmacol; 2008 Jun; 8(3):352-7. PubMed ID: 18353722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myostatin blockade therapy for muscular atrophy].
    Sunada Y
    Brain Nerve; 2011 Nov; 63(11):1271-7. PubMed ID: 22068480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine aging in men. Andropause and somatopause.
    Anawalt BD; Merriam GR
    Endocrinol Metab Clin North Am; 2001 Sep; 30(3):647-69. PubMed ID: 11571935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is there a place for DHEA, GH and melatonin in the management of age-related androgen deficiency?].
    Estour B; Bossu C; Nicolau A; Rossi D; Tostain J
    Prog Urol; 2004 Nov; 14(5):851-8. PubMed ID: 15747633
    [No Abstract]   [Full Text] [Related]  

  • 35. Hormones and Muscle Atrophy.
    Martín AI; Priego T; López-Calderón A
    Adv Exp Med Biol; 2018; 1088():207-233. PubMed ID: 30390253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
    Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal substitution in older men.
    Pugeat M; Fimbel S; Crave JC; Déchaud H; Lejeune H
    Horm Res; 1995; 43(1-3):104-10. PubMed ID: 7721255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone supplementation in the elderly.
    Nass R; Park J; Thorner MO
    Endocrinol Metab Clin North Am; 2007 Mar; 36(1):233-45. PubMed ID: 17336743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of muscular atrophy by AAV-SaCas9-mediated myostatin gene editing in aged mice.
    Weng S; Gao F; Wang J; Li X; Chu B; Wang J; Yang G
    Cancer Gene Ther; 2020 Dec; 27(12):960-975. PubMed ID: 32398787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease.
    Zhang L; Rajan V; Lin E; Hu Z; Han HQ; Zhou X; Song Y; Min H; Wang X; Du J; Mitch WE
    FASEB J; 2011 May; 25(5):1653-63. PubMed ID: 21282204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.